News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
163 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27455)
Month
January (2434)
February (2867)
March (3030)
April (3117)
May (3356)
June (2726)
July (2287)
August (2491)
September (2814)
October (2333)
Day
1 (180)
2 (176)
3 (166)
4 (36)
6 (28)
7 (20)
8 (209)
9 (212)
10 (153)
11 (45)
13 (31)
14 (133)
15 (141)
16 (97)
17 (129)
18 (39)
20 (21)
21 (93)
22 (125)
23 (160)
24 (113)
25 (42)
27 (22)
28 (135)
29 (163)
30 (145)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
27
28
29
30
Manufacturing
3 steps for taking on Novartis in radiopharma: Curium up first
To successfully challenge Novartis on two planned fronts, Curium will need to overcome the unique challenges posed by radiopharmaceutical supply to get products to patients and win market share.
September 29, 2026
·
4 min read
·
Nick Paul Taylor
Press Releases
DeepoMe Introduces RootMap, a Foundational Framework for Root-Cause Medicine in Longevity Research
New preprint connects foundational biological capabilities with organ-aging patterns and places aging hallmarks and Traditional Chinese Medicine concepts in a shared analytical space
September 29, 2026
·
1 min read
Press Releases
Five Aponermin Studies Presented at the 23rd IMS Annual Meeting, Spanning Frail Newly Diagnosed and Hard-to-Treat Relapsed/Refractory Multiple Myeloma
Studies evaluate Aponermin combined with proteasome inhibitors, immunomodulatory drugs, cytotoxic agents, XPO-1 inhibitors, and BCL-2 inhibitors
September 29, 2026
·
1 min read
Press Releases
Hiteck Presents Aponermin Data in Advanced Chondrosarcoma and Relapsed/Refractory Myeloma at CSCO 2026
Two prospective, multicenter studies delivered as oral presentations extend the clinical exploration of the DR4/DR5 agonist from hematologic malignancies into solid tumors
September 29, 2026
·
1 min read
Press Releases
Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596
September 29, 2026
·
4 min read
Press Releases
IBA signs contract to install the first proton therapy center in central Italy, in Rome
September 29, 2026
·
3 min read
Press Releases
Pharming announces CEO transition
September 29, 2026
·
4 min read
Press Releases
Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
September 29, 2026
·
4 min read
Press Releases
Genflow Biosciences PLC Announces Half-year Financial Report
September 29, 2026
·
19 min read
Press Releases
Spago Nanomedical to Participate in Several International Industry Conferences During Autumn 2026
September 29, 2026
·
3 min read
1 of 17
Next
